These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8553557)

  • 1. Analysis of the leader and capsid coding regions of persistent and neurovirulent strains of Theiler's virus.
    Michiels T; Jarousse N; Brahic M
    Virology; 1995 Dec; 214(2):550-8. PubMed ID: 8553557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure of a highly virulent Theiler's murine encephalomyelitis virus (GDVII) and implications for determinants of viral persistence.
    Luo M; Toth KS; Zhou L; Pritchard A; Lipton HL
    Virology; 1996 Jun; 220(1):246-50. PubMed ID: 8659122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theiler's murine encephalomyelitis virus (TMEV): the role of a small out-of-frame protein in viral persistence and demyelination.
    Obuchi M; Ohara Y
    Jpn J Infect Dis; 1999 Dec; 52(6):228-33. PubMed ID: 10738359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptation of Theiler's virus to L929 cells: mutations in the putative receptor binding site on the capsid map to neutralization sites and modulate viral persistence.
    Jnaoui K; Michiels T
    Virology; 1998 May; 244(2):397-404. PubMed ID: 9601508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity.
    Jnaoui K; Minet M; Michiels T
    J Virol; 2002 Aug; 76(16):8138-47. PubMed ID: 12134019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CD4-mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations.
    Rodriguez M; Roos RP; McGavern D; Zoecklein L; Pavelko K; Sang H; Lin X
    Virology; 2000 Sep; 275(1):9-19. PubMed ID: 11017783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UDP-galactose transporter is required for Theiler's virus entry into mammalian cells.
    Hertzler S; Kallio P; Lipton HL
    Virology; 2001 Aug; 286(2):336-44. PubMed ID: 11485401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A neutralization site of DA strain of Theiler's murine encephalomyelitis virus important for disease phenotype.
    Sato S; Zhang L; Kim J; Jakob J; Grant RA; Wollmann R; Roos RP
    Virology; 1996 Dec; 226(2):327-37. PubMed ID: 8955052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetics of the persistent infection and demyelinating disease caused by Theiler's virus.
    Brahic M; Bureau JF; Michiels T
    Annu Rev Microbiol; 2005; 59():279-98. PubMed ID: 16153171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of a Theiler-like virus isolated from rats.
    Ohsawa K; Watanabe Y; Miyata H; Sato H
    Comp Med; 2003 Apr; 53(2):191-6. PubMed ID: 12784854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leader (L) of Theiler's murine encephalomyelitis virus (TMEV) is required for virus growth in a murine macrophage-like cell line.
    Ichinose-Asakura K; Taniura N; Himeda T; Nojiri M; Okuwa T; Ohara Y
    Virus Res; 2010 Feb; 147(2):224-30. PubMed ID: 19932140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of cellular mutants resistant to Theiler's virus infection: differential infection of L929 cells by persistent and neurovirulent strains.
    Jnaoui K; Michiels T
    J Virol; 1999 Sep; 73(9):7248-54. PubMed ID: 10438812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of sialyloligosaccharide binding in Theiler's virus persistence.
    Zhou L; Lin X; Green TJ; Lipton HL; Luo M
    J Virol; 1997 Dec; 71(12):9701-12. PubMed ID: 9371636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric Theiler's virus with altered tropism for the central nervous system.
    Jarousse N; Fiette L; Grant RA; Hogle JM; McAllister A; Michiels T; Aubert C; Tangy F; Brahic M; Peña Rossi C
    J Virol; 1994 May; 68(5):2781-6. PubMed ID: 8151749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel neuropathogenic Theiler's murine encephalomyelitis virus.
    Buckwalter MR; Nga PT; Gouilh MA; Fiette L; Bureau JF; Laird ME; Buchrieser J; Ozden S; Cheval J; Eloit M; Manuguerra JC; Gessain A; Brey PT; Fontanet A; Albert ML
    J Virol; 2011 Jul; 85(14):6893-905. PubMed ID: 21543488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of Theiler's murine encephalomyelitis virus (TMEV) VP1 carboxyl region on the virus-induced central nervous system disease.
    Senkowski A; Shim B; Roos RP
    J Neurovirol; 1995 Mar; 1(1):101-10. PubMed ID: 9222346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.
    Fuller KG; Olson JK; Howard LM; Croxford JL; Miller SD
    Methods Mol Med; 2004; 102():339-61. PubMed ID: 15286394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An insect picorna-like virus, Plautia stali intestine virus, has genes of capsid proteins in the 3' part of the genome.
    Sasaki J; Nakashima N; Saito H; Noda H
    Virology; 1998 Apr; 244(1):50-8. PubMed ID: 9581777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single amino acid change determines persistence of a chimeric Theiler's virus.
    Jarousse N; Grant RA; Hogle JM; Zhang L; Senkowski A; Roos RP; Michiels T; Brahic M; McAllister A
    J Virol; 1994 May; 68(5):3364-8. PubMed ID: 7512164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a chimeric Theiler's murine encephalomyelitis virus containing the leader gene of foot-and-mouth disease virus.
    Piccone ME; Chen HH; Roos RP; Grubman MJ
    Virology; 1996 Dec; 226(1):135-9. PubMed ID: 8941332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.